{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T11:32:28Z","timestamp":1785670348902,"version":"3.56.0"},"reference-count":65,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2015,5,30]]},"DOI":"10.3233\/jad-142349","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T04:01:30Z","timestamp":1575345690000},"page":"497-506","source":"Crossref","is-referenced-by-count":64,"title":["Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer\u2019s Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline"],"prefix":"10.1177","volume":"46","author":[{"given":"Claudia","family":"Altamura","sequence":"first","affiliation":[{"name":"Neurology Unit, Universit\u00e0 Campus Bio-Medico di Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacarla","family":"Ventriglia","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Fatebenefratelli Foundation, AFaR Division, Fatebenefratelli Hospital-Isola Tiberina, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giulia","family":"Martini","sequence":"additional","affiliation":[{"name":"Neurology Unit, Universit\u00e0 Campus Bio-Medico di Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Montesano","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Napoli Federico II, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Errante","sequence":"additional","affiliation":[{"name":"Department of Radiology, Universit\u00e0 Campus Bio-Medico di Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Piscitelli","sequence":"additional","affiliation":[{"name":"Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Pozzuoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Scrascia","sequence":"additional","affiliation":[{"name":"Neurology Unit, Universit\u00e0 Campus Bio-Medico di Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Quattrocchi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Universit\u00e0 Campus Bio-Medico di Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Palazzo","sequence":"additional","affiliation":[{"name":"Neurology Unit, Universit\u00e0 Campus Bio-Medico di Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serenella","family":"Seccia","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Napoli Federico II, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Vernieri","sequence":"additional","affiliation":[{"name":"Neurology Unit, Universit\u00e0 Campus Bio-Medico di Roma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[{"name":"Endocannabinoid Research Group, Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche, Pozzuoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-142349_ref1","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1212\/WNL.0000000000001013","article-title":"Synaptic effects of cannabinoids: Complexity, behavioral effects, and potential clinical implications","volume":"83","author":"Benarroch","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-142349_ref2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fphar.2014.00037","article-title":"Cannabinoids for treatment of Alzheimer\u2019s disease: Moving toward the clinic","volume":"5","author":"Aso","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.3233\/JAD-142349_ref3","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/febs.12260","article-title":"Modulating the endocannabinoid system in human health and disease\u2013successes and failures","volume":"280","author":"Pacher","year":"2013","journal-title":"FEBS J"},{"key":"10.3233\/JAD-142349_ref4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Galiegue","year":"1995","journal-title":"Eur J Biochem"},{"key":"10.3233\/JAD-142349_ref5","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.2174\/138161208785740027","article-title":"The role of the endocannabinoid system in Alzheimer\u2019s disease: Facts and hypotheses","volume":"14","author":"Bisogno","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.3233\/JAD-142349_ref6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3940(02)00936-9","article-title":"Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide","volume":"332","author":"Milton","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-142349_ref7","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s00018-006-6037-3","article-title":"Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: Effect of pharmacological elevation of endocannabinoid levels","volume":"63","author":"van der Stelt","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-142349_ref8","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3233\/JAD-130137","article-title":"CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in A\u03b2PP\/PS1 mice","volume":"35","author":"Aso","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-142349_ref9","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer\u2019s disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ram\u00edrez","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-142349_ref10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.brainres.2009.05.098","article-title":"The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages","volume":"1283","author":"Tol\u00f3n","year":"2009","journal-title":"Brain Res"},{"key":"10.3233\/JAD-142349_ref11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1871527311312010011","article-title":"Neuroglial roots of neurodegenerative diseases: Therapeutic potential of palmitoylethanolamide in models of Alzheimer\u2019s disease","volume":"12","author":"Scuderi","year":"2013","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.3233\/JAD-142349_ref12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-9-8","article-title":"Prolonged oral cannabinoid administration prevents neuroinflammation, lowers \u03b2-amyloid levels and improves cognitive performance in Tg APP 2576 mice","volume":"9","author":"Mart\u00edn-Moreno","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-142349_ref13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3233\/JAD-141635","article-title":"The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer\u2019s Disease","volume":"43","author":"Bedse","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-142349_ref14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3233\/JAD-140492","article-title":"Type-1 cannabinoid receptor activity during Alzheimer\u2019s disease progression","volume":"42","author":"Manuel","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-142349_ref15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3233\/JAD-131910","article-title":"Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer\u2019s disease","volume":"40","author":"Bedse","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-142349_ref16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mcn.2013.06.004","article-title":"Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier","volume":"56","author":"Bachmeier","year":"2013","journal-title":"Mol Cell Neurosci"},{"key":"10.3233\/JAD-142349_ref17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000338494","article-title":"CB1 cannabinoid receptor activation rescues amyloid beta-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones","volume":"29","author":"Haghani","year":"2012","journal-title":"Cell Physiol Biochem"},{"key":"10.3233\/JAD-142349_ref18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neulet.2011.11.044","article-title":"Protective effect of cannabinoid CB1 receptor activation against altered intrinsic repetitive firing properties induced by Abeta neurotoxicity","volume":"507","author":"Haghani","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-142349_ref19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-2012-111862","article-title":"CB1 agonist ACEA protects neurons and reduces the cognitive impairment of AbetaPP\/PS1 mice","volume":"30","author":"Aso","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-142349_ref20","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: Relevance to Alzheimer\u2019s disease","volume":"79","author":"Martin-Moreno","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.3233\/JAD-142349_ref21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.neuropharm.2012.05.013","article-title":"WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-gamma pathway","volume":"63","author":"Fakhfouri","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-142349_ref22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.neulet.2006.06.012","article-title":"CB1 receptor selective activation inhibits beta-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons","volume":"404","author":"Esposito","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-142349_ref23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00109-005-0025-1","article-title":"The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt\/beta-catenin pathway rescue in PC12 cells","volume":"84","author":"Esposito","year":"2006","journal-title":"J Mol Med (Berl)"},{"key":"10.3233\/JAD-142349_ref24","doi-asserted-by":"crossref","first-page":"11256","DOI":"10.1073\/pnas.1016442108","article-title":"Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging","volume":"108","author":"Albayram","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-142349_ref25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2011.01.024","article-title":"Endocannabinoid2-arachidonoylglycerol protects neurons against beta-amyloid insults","volume":"178","author":"Chen","year":"2011","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-142349_ref26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.cell.2012.01.037","article-title":"Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD","volume":"148","author":"Han","year":"2012","journal-title":"Cell"},{"key":"10.3233\/JAD-142349_ref27","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/nn1801","article-title":"Cannabinoids reveal importance of spike timing coordination in hippocampal function","volume":"9","author":"Robbe","year":"2006","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-142349_ref28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.bjp.0707517","article-title":"Cannabinoid receptors in acute and chronic complications of atherosclerosis","volume":"153","author":"Mach","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"Suppl 1","key":"10.3233\/JAD-142349_ref29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2826.2008.01685.x","article-title":"The role of the endocannabinoid system in atherosclerosis","volume":"20","author":"Mach","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"10.3233\/JAD-142349_ref30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1046\/j.1432-1327.2001.01942.x","article-title":"Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor","volume":"268","author":"MacCarrone","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.3233\/JAD-142349_ref31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1476-5381.2012.02042.x","article-title":"Targeting cannabinoid receptor CB(2) in cardiovascular disorders: Promises and controversies","volume":"167","author":"Steffens","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.3233\/JAD-142349_ref32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000285520","article-title":"The vascular hypothesis of Alzheimer\u2019s disease: Bench to bedside and beyond","volume":"7","author":"de la Torre","year":"2010","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-142349_ref33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3233\/JAD-2011-101968","article-title":"The role of carotid atherosclerosis in Alzheimer\u2019s disease progression","volume":"25","author":"Silvestrini","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-142349_ref34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-142349_ref35","doi-asserted-by":"crossref","first-page":"1127.e1121","DOI":"10.1016\/j.neurobiolaging.2011.11.027","article-title":"Vascular predictors of cognitive decline in patients with mild cognitive impairment","volume":"33","author":"Viticchi","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-142349_ref36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1148\/radiol.2292030516","article-title":"Carotid artery stenosis: Gray-scale and Doppler US diagnosis\u2013Society of Radiologists in Ultrasound Consensus Conference","volume":"229","author":"Grant","year":"2003","journal-title":"Radiology"},{"key":"10.3233\/JAD-142349_ref37","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.STR.29.6.1116","article-title":"Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause","volume":"29","author":"Sutton-Tyrrell","year":"1998","journal-title":"Stroke"},{"key":"10.3233\/JAD-142349_ref38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000097034","article-title":"Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006","volume":"23","author":"Touboul","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"10.3233\/JAD-142349_ref39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1212\/WNL.53.2.315","article-title":"Norms for the Mini-Mental State Examination in a healthy population","volume":"53","author":"Grigoletto","year":"1999","journal-title":"Neurology"},{"key":"10.3233\/JAD-142349_ref41","first-page":"78","article-title":"Standardizzazione e taratura italiana dei test neuropsicologici.78-80","volume":"Suppl 8","author":"Spinnler","year":"1987","journal-title":"Ital J Neurol Sci"},{"key":"10.3233\/JAD-142349_ref42","volume-title":"Neuropsychological Assessment","author":"Lezak","year":"2004","edition":"4"},{"key":"10.3233\/JAD-142349_ref43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10278-004-1014-6","article-title":"OsiriX: An open-source software for navigating in multidimensional DICOM images","volume":"17","author":"Rosset","year":"2004","journal-title":"J Digit Imaging"},{"key":"10.3233\/JAD-142349_ref44","first-page":"35","article-title":"Radial width of the temporal horn: A sensitive measure in Alzheimer disease","volume":"23","author":"Frisoni","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.3233\/JAD-142349_ref45","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.lfs.2005.05.012","article-title":"The search for the palmitoylethanolamide receptor","volume":"77","author":"LoVerme","year":"2005","journal-title":"Life Sci"},{"key":"10.3233\/JAD-142349_ref46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/3-540-26573-2_15","article-title":"Cannabinoid function in learning, memory and plasticity","author":"Riedel","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"10.3233\/JAD-142349_ref47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ddr.20334","article-title":"Are CB(1) receptor antagonists nootropic or cognitive impairing agents?","volume":"70","author":"Varvel","year":"2009","journal-title":"Drug Dev Res"},{"key":"10.3233\/JAD-142349_ref48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejphar.2003.08.026","article-title":"Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade","volume":"477","author":"Mazzola","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JAD-142349_ref49","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/npp.2012.25","article-title":"Palmitoylethanolamide protects against the amyloid-\u03b225-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease","volume":"37","author":"D\u2019Agostino","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-142349_ref50","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.1523\/JNEUROSCI.2075-11.2011","article-title":"Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice","volume":"31","author":"Pan","year":"2011","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-142349_ref51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fnbeh.2011.00057","article-title":"Effects of endocannabinoid system modulation on cognitive and emotional behavior","volume":"5","author":"Zanettini","year":"2011","journal-title":"Front Behav Neurosci"},{"key":"10.3233\/JAD-142349_ref52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1160\/TH05-06-0413","article-title":"Regulation by cannabinoid receptors of anandamide transport across the blood-brain barrier and through other endothelial cells","volume":"95","author":"Maccarrone","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.3233\/JAD-142349_ref53","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2174\/138161208785740018","article-title":"The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases","volume":"14","author":"Centonze","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.3233\/JAD-142349_ref54","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1192\/bjp.bp.112.121178","article-title":"Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms","volume":"202","author":"Morgan","year":"2013","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-142349_ref55","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/npp.2013.165","article-title":"Peripheral endocannabinoid system dysregulation in first-episode psychosis","volume":"38","author":"Bioque","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-142349_ref56","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.schres.2014.04.028","article-title":"Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia","volume":"156","author":"Ferretjans","year":"2014","journal-title":"Schizophr Res"},{"key":"10.3233\/JAD-142349_ref57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-511X-9-43","article-title":"Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients","volume":"9","author":"Annuzzi","year":"2010","journal-title":"Lipids Health Dis"},{"key":"10.3233\/JAD-142349_ref58","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.neurobiolaging.2012.06.005","article-title":"CB2 receptor and amyloid pathology in frontal cortex of Alzheimer\u2019s disease patients","volume":"34","author":"Solas","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-142349_ref59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF01001351","article-title":"Neurochemical aspects of Alzheimer\u2019s disease: Involvement of membrane phospholipids","volume":"3","author":"Farooqui","year":"1988","journal-title":"Metab Brain Dis"},{"key":"10.3233\/JAD-142349_ref60","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12031-014-0371-y","article-title":"Endocannabinoid 2-arachidonylglycerol protects primary cultured neurons against homocysteine-induced impairments in rat caudate nucleus through CB1 receptor","volume":"55","author":"Dong","year":"2015","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-142349_ref61","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-511X-8-2","article-title":"Endocannabinoids in Alzheimer\u2019s disease and their impact on normative cognitive performance: A case-control and cohort study","volume":"8","author":"Koppel","year":"2009","journal-title":"Lipids Health Dis"},{"key":"10.3233\/JAD-142349_ref62","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.atherosclerosis.2008.03.011","article-title":"The endocannabinoid system and cardiometabolic risk","volume":"199","author":"Szmitko","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.3233\/JAD-142349_ref63","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3233\/JAD-2012-121240","article-title":"Cerebrovascular assessment for the risk prediction of Alzheimer\u2019s disease","volume":"32","author":"Silvestrini","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-142349_ref64","doi-asserted-by":"crossref","first-page":"e53390","DOI":"10.1371\/journal.pone.0053390","article-title":"Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation","volume":"8","author":"Iring","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-142349_ref65","first-page":"H1859","article-title":"Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin","volume":"269","author":"Ellis","year":"1995","journal-title":"Am J Physiol"},{"key":"10.3233\/JAD-142349_ref66","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(01)01112-8","article-title":"Hemodynamic effects of cannabinoids: Coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors","volume":"423","author":"Wagner","year":"2001","journal-title":"Eur J Pharmacol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-142349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:02:12Z","timestamp":1777370532000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-142349"}},"subtitle":[],"editor":[{"given":"Jack","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,30]]},"references-count":65,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-142349","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,30]]}}}